CD24 and neoplasm: We also observed that the tumor-suppressive efficacy of nanomaterials encapsulated in unmodified EM was inferior to that of those delivered via anti-CD24-modified EM, underscoring the necessity of targeted surface modification to enhance therapeutic performance (Fig. 3C).